Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Alloplastic Esthetic
Facial Augmentation
Bruce N. Epken DDS, M5D, PhD
lous surgical technique, proper modification, and placement of the implant are
essential. Accordingly, this chapter
emphasizes and details these aspects of
esthetic facial augmentation.
An additional item discussed herein is
still controversialthe use of antibiotics
with surgery for alloplastic facial augmentation. A recent survey of surgeons revealed
a spectrum of opinions. Approximately
30% of surgeons use no antibiotics or
intravenous antibiotics only during
surgery. About an additional 30% continue
antibiotics for 1 to 3 days postoperatively,
and 40% use them for 4 to 7 days postoperatively.'^ Unfortunately, the incidence of
infection with the various regimens is not
available; however, the overall incidence is
very low. I use a single intraoperative dose
of intravenous antibiotics at the commencement of surgery; generally, I use
cephalosporin regardless of whether an
extraoral or intraoral approach is taken.'^''*
Finally, alloplastic nasal augmentation
is not discussed here as, in general, I prefer
autogenous materials for this purpose.
The Chin
Alloplastic chin augmentation is generally
reserved for the patient who has lax and/or
redundant soft tissues or who is undergoing simultaneous neck surgery, such as
1436
1437
1438
D
FIGURE 70-2 Preoperative (A and C) and postoperative (B and D) photographs of a patient who underwent chin augmentation to reduce a pointed chin appearance illustrating more lateral augmentations.
syringe and evacuating all air, and repeatedly withdrawing the plunger forcefully
while holding a finger over the end of the
syringe. This removes the air from the
porous implant and replaces it with the
concentrated antibiotic solution. The procedure requires considerable effort and
pressure, often taking a few minutes.
When this process reaches its end point,
the implant sinks in the solution.
|
The initial try-in is then done. Additional modifications are often necessary,
such as notching the implant in the
region of tbe mental neurovascular bundle and molding it slightly into a curved
1439
1440
1441
1442
FIGURE 70-11
1443
The limited exposure can be performed witiiout significant effech on the nose or upper lip.
FIGURE 70-12 Preoperative (A and C) postoperative (B and D ) appearances after an extended approach with an alar cinch and a V-Y augmentation ofthe upper
lip. Reproduced with permission from Epker BN.^'' p. 130-1.
1444
son's locates the prominence quite inferiorly, and Prendergast and Schoenrock's
locates it medially. Powell and colleagues'
analysis is comparable with the frontal
view values recommended by tbe author.
In the three-quarters oblique esthetic
assessment, the esthetically attractive contralateral cheek prominence extends well
beyond a line from the lateral commissure
A detailed systematic esthetic examina- of the mouth to the lateral canthus. Its
tion of this area is performed because the most prominent location is about 15 to
evaluation of this area of the face must be 20 mm beneath the lateral canthus.
multidirectional. Esthetic judgments
The basal view simply supplements
made exclusively from a single view are the findings from the other perspectives
incomplete witb respect to the specificity and also reveals both the true lateral and,
of the deficiency.
to a levSser degree, anterior projections of
Frontally the area of maximum cheek the cheeks. This view is important to best
prominence is located about 10 mm lateral determine the symmetry of tbe cbeeks.
and 15 mm to 20 mm inferior to the laterThe surgeon must not only evaluate
al canthus. The cbeek prominence is posi- the cheek prominence proper but also the
tioned more laterally than the mandibular buccal area because excessive fullness in the
angle. The bizygomatic width of the esthet- buccal region can lead the surgeon to the
ically attractive face is the widest dimen- erroneous iMpression that cheek deficiency
sion of the face, with the bitemporal width exists. When cheek deficiency and buccal
and bigonial widths following. Silver has fullness coexist, the surgeon must exercise
defmed a malar prominence triangle, caution with respect to whether and how
which very closely locates the malar promi- much cheek augmentation versus buccal
nence to this same location.^^
fat pad reduction is to be performed.
A mark is made on the face in the ideal
From the profile perspective, the
cheek prominence and infraorbital rim in region of the cheek eminence, 10 mm latthe esthetically attractive individual are eral and 15 to 20 mm inferior to the latersituated so that the infraorbital rim is al canthus. This mark aids in the proper
about equally projected with the anterior- superoinferior and lateral positioning of
most projection of the globe, and the the cheek implant. Similarly, it helps in
cheek prominence is located several mil- predetermining the desired lateral and
limeters anterior to the globe. This rela- anteroposterior thickness of the cheek
tionship results in the cheek area being augmentation. It is important to create a
clearly convex in its configuration, as gentle convex surface curvature beginning
in the infraorbital area and extending infeopposed to flat or concave.
Most analyses of the malar promi- riorly 15 to 20 mm. In concert with this
nence that have been described in the lit- marking, a tangent from the soft tissue
erature are from the three-quarters view. gonial angle to this region is constructed
These include Hinderer's, Wilkinson's, with a ruler to "estimate" the desired laterPowell and colleagues', and Prendergast al projection as determined by the criteria
and Schoenrock's methods.^^"-*"* These previously discussed.
The procedure can be readily permethods result in highly variable ideal
locations for the malar prominence, both formed under either general anesthesia
vertically and laterally. Specifically, Hin- supplemented with a local anesthetic
derer's method is too nonspecific, Wilkin- with 1:200,000 epinephrine, or local
objective criteria of the long-face syndrome. This is because of the abnormal
facial length-to-width relationships caused
by the abnormal narrow bizygomatic
width. Similarly, poor cheek projection is
noted in tbe three-quarter oblique view. In
profile these same individuals possess variable degrees of inadequate cheek and/or
lateral infraorbital rim projection.'"^'^^
anesthesia and sedation. About 10 minutes before surgery the infraorbital nerves
are blocked bilaterally with a few cubic
centimeters of 2% lidocaine with
1:200,000 epinephrine. A few minutes
later the entire maxillary vestibule is infiltrated transorally with approximately
10 cc of the same agent, from the zygomatic-alveolar crest area on one side to
the same area on the opposite side. In
addition, the subperiosteal dissection
extends laterally along the zygomatic arch.
FIGURE 70-14 Symmetric and good stabilization of the right and left cheek implants is best
achieved with screw fixation. Adapted from
Epker BN.'''p 152.
D
FIGURE 70-15 Preoperative (A, C and E) and postoperative (B, D, and f} appearances of a patient who underwent a
cheek augmentation. Reproduced with permission from Epker BNJ^ p. 156-7.
1445
1446
Summary
Alloplastic facial augmentation has
become a standard of care. Careful preoperative detailed systematic esthetic evaluations permit the various areas of the face
to be augmented precisely.
References
L Yaremchuk MJ, Rubin JP, Posnick JC, et al.
Implantable materials in facial aesthetic
and reconstructive surgery: biocompatibility and clinical application. | Craniofac Surg
1996:7:473-84.
2. Rubin JP, Yaremchuk MJ. Complications and
toxicities of implantable biomaterials used in
facial reconstructive and aesthetic surgery; a
comprehensive review of the literature. Plast
ReconstrSurg 1997; 100:1336-45.
3. Silver FH, Maas CS. Biology of synthetic facial
implant materials. Facial Plastic Surg Clin
North Am 1994:2:241-53.
4. Singh S, Baker JL. Use of expanded
tetraflouroethylene in aesthetic surgery of
the face. Chn Plast Surg 2000;27:579-93.
5. Levine B, Berman WE. The current status of
expanded polytetraflouroethylene (GoreTex) in facial plastic surgery. Ear Nose
Throat I 1995;74:681-84.
6. Frodel |L, Lee S. The use of high-density polyethylene implants in facial deformities.
Arch Otolaryngol Head Neck Surg
1998;124:1219-23.
7. Spector M, Flemming WR, Sauer BW, et al.
Early tissue infiltrate in porous polyethylene implants into bone: a scanning EM
study. I Biomed Mater Res 1975;9:537-45.
8. Weltisz T, et al. Characteristics of tissue
response to MedPor porous polyethylene
implants in the human face. I Long Term
Effects MedPor Implant 1993:3:223-35.
9. Karras SC, Wolford LM. Augmentation genioplasty with hard tissue replacement implants.
J Oral Maxillofac Surg 1998;56:549-52.
10. Pearson DC, Sherris DA. Resorption beneath
Silastic mandibular implants. Arch Otolaryngol Head Neck Surg 1999:1:261-4.
11. Vuyk HD. Augmentation mentoplasty with solid
sUicone. Clin Otolaryngol 1996:21:106-18.
12. Perrotti JD, Castor SA, Perez PC, Zins IE.
Antibiotic use in esthetic surgery: a national survey and literature review. Plast Reconst Surg 2002:15:1685-93.
13. Holz G, Novotny-Lenhard), Kinzig M, Soergel F.
Single dose antibiotic prophylaxis in maxillofacial surgery. Chemotherapy 1994:40:65-9.
14. Sylaidas P. Postoperative infection following
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
1447